Time to scale up molecular surveillance for anti-malarial drug resistance in sub-Saharan Africa (Publications)
Artemisinin resistance has emerged and spread in the Greater Mekong Sub-region (GMS), followed by artemisinin-based combination therapy failure, due to both artemisinin and partner drug resistance. Mo
Estimating intervention effectiveness in trials of malaria interventions with contamination (Publications)
Background In cluster randomized trials (CRTs) or stepped wedge cluster randomized trials (SWCRTs) of malaria interventions, mosquito movement leads to contamination between trial arms unless buffer z
The additive effect of interpregnancy interval and maternal body mass index on pregnancy induced hypertension in the U.S (Publications)
OBJECTIVES: The incidence of pregnancy induced hypertension (PIH), one of the most frequent causes of maternal and neonatal morbidity, has increased significantly in the U.S. in last two decades. Howe
Extracellular matrix-induced GM-CSF and hypoxia promote immune control of<em> Mycobacterium tuberculosis </em>in human <em>in vitro</em> granulomas (Publications)
Several in vitro cellular models have been developed with the aim to reproduce and dissect human granulomatous responses, the hallmark of tuberculosis (TB) immunopathogenesis. In that context, we comp
Spatio-temporal visualisation of cutaneous leishmaniasis in an endemic, urban area in Iran (Publications)
INTRODUCTION: Cutaneous Leishmaniasis (CL) is a significant public health concern worldwide. Iran is among the most CL-affected countries, being one of the six most endemic countries in the world. Thi
Digitalisation of a clinical algorithm (according to decision logic provided by MSF) into an existing CHT mobile application called MSFeCARE (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/digitalisation-of-a-clinical-algorithm-according-to-decision-logic-provided-by-msf-into-an-existing-cht-mobile-application-called-msfecare
Development of a clinical algorithm (in English/French) providing clinical decision support to Médicins sans Frontières (MSF) staff in clinics caring for patients with sexually transmitted infections
Swiss science diplomacy after a decade of global geopolitical turbulences: development and outcomes (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/swiss-science-diplomacy-after-a-decade-of-global-geopolitical-turbulences-development-and-outcomes
Background: The concept of science diplomacy saw a surge of interest with the start of the new Millennium, especially in Japan, the United Kingdom and the United States. In 2009, the UK’s Royal Societ
Strengthening research data management capacity at the Papua New Guinea Institute of Medical Research (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/strengthening-research-data-management-capacity-at-the-papua-new-guinea-institute-of-medical-research
High quality accessible data is the basis of sound medical and public health research. Health research institutions around the world therefore require sufficient capacity to generate, manage, analyse
Technical Assistance on Development of Quality Improvement Action Plan for the National TB Program in Tajikistan (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/technical-assistance-on-development-of-quality-improvement-action-plan-for-the-national-tb-program-in-tajikistan
In Tajikistan, an estimated 7800 people fell ill with active TB in 2022. In terms of multidrug-resistant TB (MDR-TB), Tajikistan belongs to the 27 countries with the highest burden (globally). To opti